10:55 AM EDT, 05/27/2025 (MT Newswires) -- Catheter Precision ( VTAK ) said Tuesday it has received CE Mark approval for its vascular closure device LockeT.

The company said it can now offer the LockeT device, registered with the US Food and Drug Administration, in EU regions and additional markets, including the UK, Switzerland, and Turkey.

The medical device company said it has received its first order for 100 units from the EU.

Shares of Catheter Precision ( VTAK ) were down past 13% in recent Tuesday trading.

Price: 0.21, Change: -0.03, Percent Change: -13.42